CL
Insider
Cormorant Asset Management, LP
OtherCormorant Asset Management, LP (Other) filed 3 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 3 sales), most often in Corbus Pharmaceuticals Holdings, Inc. (CRBP). The largest single filing was $9.8M of DRUG (109,331 sh × $89.50, as filed), executed Apr 28. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$12.5M
shares × price, as filed
Last traded
Oct 29
Filed Nov 2
Median ADV $5.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $12.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Not on file
2 filings
Sector per market data · by filing · past 12 months
Most traded names
CRBPRecent filings
CRBPSALE
Corbus Pharmaceuticals Holdings, Inc.
View filing →
$1.7M425,000 sh × $4.10
Exec Oct 29
Filed Nov 2 · 4:05 PM ET DRUGSALE BRIGHT MINDS BIOSCIENCES INC. View filing → $9.8M
109,331 sh × $89.50
Exec Apr 28
Filed Apr 30 · 5:30 PM ET EYPTSALE EyePoint, Inc. View filing → $942K
60,000 sh × $15.70
Exec Dec 4 2025
Filed Dec 8 2025 · 5:30 PM ET DRUGPURCHASE BRIGHT MINDS BIOSCIENCES INC. View filing → $4.0M
184,331 sh × $21.70
Exec Nov 4 2024
Filed Nov 6 2024 · 5:30 PM ET